Usp9X Regulates Cell Death in Malignant Peripheral Nerve Sheath Tumors

Area of Science:

• Oncology
• Molecular Biology
• Biochemistry

Background:

• Malignant peripheral nerve sheath tumors (MPNSTs) are a primary cause of mortality in neurofibromatosis type 1 (NF1) patients.
• Existing treatments for MPNSTs have shown limited success in improving patient survival rates.
• There is an urgent need for novel therapeutic targets to combat MPNSTs.

Purpose of the Study:

• To investigate the role of Usp9X and Mcl-1 in MPNST cell viability.
• To explore the potential of targeting Usp9X as a therapeutic strategy for MPNSTs.

Main Methods:

• Knockdown of Usp9X and Mcl-1 in human MPNST cell lines.
• Assessment of cell death pathways, including apoptosis and caspase-independent mechanisms.
• Ultrastructural analysis to identify cell death morphology.
• Pharmacological inhibition of Usp9X using WP1130 in vitro and in vivo xenograft models.

Main Results:

• Interference with Usp9X or Mcl-1 led to rapid death in human MPNST cell lines.
• MPNST cell death occurred through both apoptotic and caspase-independent pathways, characterized by paraptosis.
• The Usp9X inhibitor WP1130 significantly reduced MPNST growth and induced tumor cell death in vivo.
• Usp9X and Mcl-1 are crucial for maintaining MPNST cell viability.

Conclusions:

• Usp9X and Mcl-1 play critical roles in the survival of human MPNST cells.
• Pharmacological inhibition of Usp9X deubiquitinase activity represents a promising therapeutic avenue for MPNST treatment.